Trials / Completed
CompletedNCT05486897
Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 315 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
White matter hyperintensities (WMH) are one of the small vessel disease-related MRI characteristics of both cerebral amyloid angiopathy (CAA) and hypertensive arteriopathy (HA). WMH tend to show a peri-basal ganglia pattern in HA, whereas a multiple subcortical spots pattern can be observed in CAA. Periventricular WMH (PVWMH) have been reported to be posterior predominant using a semiautomated segmentation method and logarithmic transformation, not used in daily clinical practice. In these studies including CAA patients, patients initially presented with haemorrhage-related symptoms. In another study analysing PVWMH and cerebral amyloid evidence in patients with mild cognitive impairment, frontal PVWMH burden was associated with high uptake on florbetapir-PET whereas parietal and occipital PVWMH burden was associated with low CSF-amyloid-beta. The aim of this study is the descriptive comparative analysis of the distribution of PVWMH between CAA and HA patients with radiological tools available in daily practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None, pure observational study | None, pure observational study |
Timeline
- Start date
- 2022-09-05
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
- First posted
- 2022-08-04
- Last updated
- 2025-12-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05486897. Inclusion in this directory is not an endorsement.